Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules

Author： Nikolova Zariana   Peng Bin   Hubert Martine   Seiberling Michael   Keller Urs   Ho Yu-Yun   Schran Horst   Capdeville Renaud  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.53, Iss.5, 2004-05, pp. : 433-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?

By  

Cancer Medicine, Vol. 7, Iss. 2, 2018-02 ,pp. : 317-324

John Wiley & Sons Inc

Access to resources Recommend Favorite

Upper gastrointestinal safety and tolerability of oral alendronate: A meta-analysis

By                

Experimental and Therapeutic Medicine, Vol. 11, Iss. 1, 2016-01 ,pp. : 289-296

Spandidos Publications

Access to resources Recommend Favorite

A Phase I Trial to Determine the Safety of Imatinib in Combination With Vatalanib in Patients With Advanced Malignancies

By Spigel David   Jones Suzanne   Hainsworth John   Infante Jeff   Greco F. Anthony   Thompson Dana   Doss Habib   Burris Howard  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 308-312

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of sunitinib in Chinese patients with imatinib-resistant or -intolerant gastrointestinal stromal tumors

By Li Jian   Gao Jing   Hong Jinlin   Shen Lin  

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 617-624

Future Medicine

Access to resources Recommend Favorite

Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro

By                  

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 270-280

Spandidos Publications

Access to resources Recommend Favorite